Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Blind Randomized Study, Comparing Rifaximin vs Placebo for the Prevention of Encephalopathy in Patients Treated by TIPS

NCT02016196 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT02016196
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02016196 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Blind Randomized Study, Comparing Rifaximin vs Placebo for the Prevention of Encephalopathy in Patients Treated by TIPS
Lead sponsor
University Hospital, Toulouse
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2013
Completion date
July 31, 2017
Enrollment
211 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis